Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TFPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RBM10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EEF1D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100131053 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PSMC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ECHS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AURKAIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EDF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP6V0B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HAGH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF3G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRR14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6840 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on